von Olshausen, Gesa https://orcid.org/0000-0001-8145-0414
Paul-Nordin, Astrid
Tapanainen, Jari
Jensen-Urstad, Mats
Bastani, Hamid
Saluveer, Ott
Bourke, Tara
Drca, Nikola
Kennebäck, Göran
Saygi, Serkan
Turkmen, Yusuf
Insulander, Per
Braunschweig, Frieder
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (OL 605/1-1)
Karolinska Institute
Article History
Received: 27 January 2022
Accepted: 2 September 2022
First Online: 9 September 2022
Declarations
:
: All data collection was approved by the regional ethics committee and patient data were collected in accordance with the institutional ethics guidelines.
: M. J.-U. is a consultant for Johnson and Johnson and has received research grants from Medtronic. N. D. has received speaker fees from Biosense Webster and served as proctor for Biosense Webster and Medtronic. F. B. is a speaker or trial committee member for Medtronic, Biotronik, Biosense Webster, Boehringer, Pfizer, Orion, Novartis, Abbott, and Impulse Dynamics. For the remaining authors, no conflicts of interest are declared.